Aterian (NASDAQ:ATER) Shares Up 0.8% – What’s Next?

Aterian, Inc. (NASDAQ:ATERGet Free Report) traded up 0.8% during trading on Monday . The stock traded as high as $2.58 and last traded at $2.56. 96,263 shares were traded during trading, an increase of 3% from the average session volume of 93,053 shares. The stock had previously closed at $2.54.

Aterian Stock Down 3.7 %

The stock has a market cap of $20.66 million, a P/E ratio of -0.90 and a beta of 2.04. The business’s 50-day simple moving average is $2.75 and its two-hundred day simple moving average is $2.80.

Aterian (NASDAQ:ATERGet Free Report) last issued its earnings results on Monday, November 11th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.30. Aterian had a negative net margin of 17.05% and a negative return on equity of 56.01%. The business had revenue of $26.24 million for the quarter.

Hedge Funds Weigh In On Aterian

Several hedge funds have recently bought and sold shares of ATER. Essex Investment Management Co. LLC bought a new position in Aterian in the 3rd quarter worth about $102,000. XTX Topco Ltd purchased a new stake in shares of Aterian during the 2nd quarter valued at $59,000. Finally, Jane Street Group LLC bought a new stake in shares of Aterian during the 3rd quarter worth $33,000. Hedge funds and other institutional investors own 7.02% of the company’s stock.

About Aterian

(Get Free Report)

Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.

Featured Stories

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.